ExL Pharma's May 17th "Maximizing Portfolio Value - Are Good Projects Always Good for One's Portfolio?" Webinar Will Be Delivered Using TalkPoint Technology
On May 17th, ExL Pharma, will present an interactive webinar that will feature a Johnson and Johnson Case Study and discuss the balance of timely investments and divestitures in managing a company portfolio.

/Multimedia News Articles/ - NEW YORK, NY, May 03, 2006 - ExL Pharma, a division of ExL Events, Inc., an emerging leader in developing innovative, educational events that serve the healthcare community and allied professionals and Talkpoint, the leading provider of web-based audio and video webcasting solutions, announced today that ExL's May 17th "Maximizing Portfolio Value" Webinar will be presented using TalkPoint's webcasting technology.

Looking at the current RandD business model, Dr. Richard M. Bayney, Vice President of Portfolio Planning for Johnson and Johnson, will be discussing issues such as; 'When Does It Make Sense To Begin Investing In A Project?'; 'How Often Should You Re-Assess The Viability Of A Project?'; 'When Is It Appropriate To Walk Away From A Sunken Investment?'. Moderated by Dave Zuckerman, President of Customized Improvement Strategies, the webinar will outline portfolio requirements and needs within the current RandD business model. Dr. Bayney will also address the portfolio implications of terminating projects early and often. ExL's May 17th webinar presents arguments that assess whether or not early pain in the process can be offset by sustainable gain and will look into the strategic and economic impact of failing smart and early.

"In this time of limited resources, relentless competition and heightened public scrutiny it is imperative to a company's survival to have a dependable strategy for minimizing risk and maximizing the probability of success within the portfolio" said ExL Pharma's Program Director, Kristen Hunter.

TalkPoint will be providing ExL Pharma with a suite of solutions for their online event that include audio with synchronized slides and interactive elements such as real-time polling and live QandA.

To register for the webinar, please call 212-400-6240 or go to:
[url=http://www.exlpharma.com/events/ev_descrip.php?ev_id=34]


About ExL Pharma
ExL Pharma, a division of ExL Events, Inc., is an emerging leader in developing innovative, educational pharmaceutical conferences that serve the healthcare community and allied professionals. Behind their diverse conference portfolio, their experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality pharmaceutical conferences designed to exceed the dynamic informational needs of the healthcare community.

For more information on ExL Pharma, go to www.exlpharma.com

Press Release Contact Information:

Daniel Roche
TalkPoint
Director of Marketing
100 William St. 9th Floor
New York, NY
USA 10038
Voice: 212.404.1516
Fax: 212.404.1537
Website: Visit Our Website